The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Current understanding of HIV-associated neurocognitive disorders pathogenesis
Open accessAbstract
PURPOSE OF REVIEW: The present review discusses current concepts of HIV-associated neurocognitive disorders (HAND) in the era of antiretroviral therapy (ART). As the HIV epidemic enters its fourth decade (the second decade of ART), research must address evolving factors in HAND pathogenesis. These include persistent systemic and central nervous system (CNS) inflammation, aging in the HIV-infected brain, HIV subtype (clade) distribution, concomitant use of drugs of abuse, and potential neurotoxicity of ART drugs. RECENT FINDINGS: Although the severest form of HAND, HIV-associated dementia (HAD), is now rare due to ART, the persistence of milder, functionally important HAND forms persist in up to half of HIV-infected individuals. HAND prevalence may be higher in areas of Africa where different HIV subtypes predominate, and ART regimens that are more effective in suppressing CNS HIV replication can improve neurological outcomes. HAND are correlated with persistent systemic and CNS inflammation, and enhanced neuronal injury due to stimulant abuse (cocaine and methamphetamine), aging, and possibly ART drugs themselves. SUMMARY: Prevention and treatment of HAND requires strategies aimed at suppressing CNS HIV replication and effects of systemic and CNS inflammation in aging and substance-abusing HIV populations. Use of improved CNS-penetrating ART must be accompanied by evaluation of potential ART neurotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d727 · Cited by 2,353
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,832
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Groups, F. T. C. A. H., Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., et al. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-010-0006-1 · Cited by 1,533
Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,407
Pathways to neuronal injury and apoptosis in HIV-associated dementia
Kaul, M., Garden, G. A., & Lipton, S. A. (2001) · Nature · doi:10.1038/35073667 · Cited by 1,210
González-Scarano, F., & Martín-García, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1527 · Cited by 1,097
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Neuhaus, J., Jacobs, Jr., Baker, J. V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L. H., Pett, S. L., Ristola, M., Ross, M. J., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/652749 · Cited by 869
Letendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 825
Glass, J. D., Fedor, H., Wesselingh, S. L., & McArthur, J. C. (1995) · Annals of Neurology · doi:10.1002/ana.410380510 · Cited by 662
Jiang, W., Lederman, M. M., Hunt, P., Sieg, S. F., Haley, K., Rodriguez, B., Landay, A., Martin, J., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 591
HIV-associated cognitive impairment before and after the advent of combination therapy
Sacktor, N., McDermott, M. P., Marder, K., Schifitto, G., Selnes, O. A., McArthur, J. C., Stern, Y., Albert, S., Palumbo, D., Kieburtz, K., et al. (2002) · Journal of Neurovirology · doi:10.1080/13550280290049615 · Cited by 584
HIV disease: fallout from a mucosal catastrophe?
Brenchley, J. M., Price, D. A., & Douek, D. C. (2006) · Nature Immunology · doi:10.1038/ni1316 · Cited by 579
Conant, K., Garzino-Demo, A., Nath, A., McArthur, J. C., Halliday, W., Power, C., Gallo, R. C., & Major, E. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3117 · Cited by 577
Heyes, M. P., Brew, B. J., Martin, A., Price, R. W., Salazar, A. M., Sidtis, J. J., Yergey, J. A., Mouradian, M. M., Sadler, A. E., Keilp, J., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410290215 · Cited by 571
Genis, P., Jett, M., Bernton, E. W., Boyle, T., Gelbard, H. A., Dzenko, K., Keane, R. W., Resnick, L., Mizrachi, Y., & Volsky, D. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1703 · Cited by 531
Ancuta, P., Kamat, A., Kunstman, K. J., Kim, E.-Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Mefford, M., Morgello, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002516 · Cited by 499
Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap
McArthur, J. C., Steiner, J., Sacktor, N., & Nath, A. (2010) · Annals of Neurology · doi:10.1002/ana.22053 · Cited by 445
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 430
Food Combination and Alzheimer Disease Risk: A Protective Diet
Gu, Y. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.84 · Cited by 414
Human Immunodeficiency Virus-Associated Dementia: An Evolving Disease
McArthur, J. C., Haughey, N., Gartner, S., Conant, K., Pardo, C., Nath, A., & Sacktor, N. (2003) · Journal of Neurovirology · doi:10.1080/13550280390194109 · Cited by 379
Neurologic complications of HIV disease and their treatment.
Letendre, S. L., Ellis, R. J., Everall, I., Ances, B., Bharti, A., & McCutchan, J. A. (2006) · PubMed · Cited by 349
Marra, C. M., Zhao, Y., Clifford, D. B., Letendre, S., Evans, S., Henry, K., Ellis, R. J., Rodriguez, B., Coombs, R. W., Schifitto, G., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832c4152 · Cited by 347
Extensive astrocyte infection is prominent in human immunodeficiency virus–associated dementia
Churchill, M. J., Wesselingh, S. L., Cowley, D., Pardo, C. A., McArthur, J. C., Brew, B. J., & Gorry, P. R. (2009) · Annals of Neurology · doi:10.1002/ana.21697 · Cited by 339
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
Kroner, Z. (2009) · PubMed · Cited by 329
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin
Gelbard, H. A., Nottet, H. S., Swindells, S., Jett, M., Dzenko, K. A., Genis, P., White, R., Wang, L., Choi, Y. B., & Zhang, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4628-4635.1994 · Cited by 318
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy
Childs, E. A., Lyles, R. H., Selnes, O. A., Chen, B., Miller, E. N., Cohen, B. A., Becker, J. T., Mellors, J., & McArthur, J. C. (1999) · Neurology · doi:10.1212/wnl.52.3.607 · Cited by 305
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients
Green, D. A., Masliah, E., Vinters, H. V., Beizai, P., Moore, D. J., & Achim, C. L. (2005) · AIDS · doi:10.1097/01.aids.0000161770.06158.5c · Cited by 299
Marchetti, G., Bellistrì, G. M., Borghi, E., Tincati, C., Ferramosca, S., La Francesca, M., Morace, G., Gori, A., & Monforte, A. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283112d29 · Cited by 297
. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.
Tien, P. C., Choi, A. I., Zolopa, A. R., Benson, C., Tracy, R., Scherzer, R., Bacchetti, P., Shlipak, M., & Grunfeld, C. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e66216 · Cited by 279
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
(2009) · PubMed · Cited by 272
Influence of HAART on HIV-Related CNS Disease and Neuroinflammation
Anthony, I. C., Ramage, S. N., Carnie, F. W., Simmonds, P., & Bell, J. E. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.529 · Cited by 267
Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia
Haughey, N. J., Cutler, R. G., Tamara, A., McArthur, J. C., Vargas, D. L., Pardo, C. A., Turchan, J., Nath, A., & Mattson, M. P. (2004) · Annals of Neurology · doi:10.1002/ana.10828 · Cited by 267
Liang, J.-S., Distler, O., Cooper, D. A., Jamil, H., Deckelbaum, R. J., Ginsberg, H. N., & Sturley, S. L. (2001) · Nature Medicine · doi:10.1038/nm1201-1327 · Cited by 261
Oxidative damage in mild cognitive impairment and early Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21346 · Cited by 245
Adle‐Biassette, Chrétien, Wingertsmann, Héry, Ereau, Scaravilli, Tardieu, & Gray (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00167.x · Cited by 233
Prevalence of Alzheimer plaques in AIDS
Esiri, M. M., Biddolph, S. C., & Morris, C. S. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.29 · Cited by 227
Elevated central nervous system prostaglandins in human immunodeficiency virus—associated dementia
Griffin, D. E., Wesselingh, S. L., & McArthur, J. C. (1994) · Annals of Neurology · doi:10.1002/ana.410350513 · Cited by 225
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders
Letendre, S. L., McCutchan, J. A., Childers, M. E., Woods, S. P., Lazzaretto, D., Heaton, R. K., Grant, I., Ellis, R. J., & the HNRC Group (2004) · Annals of Neurology · doi:10.1002/ana.20198 · Cited by 222
The Changing Pattern of HIV Neuropathology in the HAART Era
Gray, F., Chrétien, F., Vallat-Decouvelaere, A. V., & Scaravilli, F. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.5.429 · Cited by 219
Smurzynski, M., Wu, K., Letendre, S., Robertson, K., Bosch, R. J., Clifford, D. B., Evans, S., Collier, A. C., Taylor, M., & Ellis, R. (2011) · AIDS · doi:10.1097/qad.0b013e32834171f8 · Cited by 218
Pathogenesis of HIV in the Central Nervous System
Valcour, V., Sithinamsuwan, P., Letendre, S., & Ances, B. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0070-4 · Cited by 211
Neurodegeneration and Ageing in the HAART Era
Brew, B. J., Crowe, S. M., Landay, A., Cysique, L. A., & Guillemin, G. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9143-1 · Cited by 207
Neurocognitive disturbances in HIV
Grant, I. (2008) · International Review of Psychiatry · doi:10.1080/09540260701877894 · Cited by 207
Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients
HNRC, Achim, C. L., Adame, A., Dumaop, W., Everall, I. P., & Masliah, E. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9152-8 · Cited by 205
Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response
Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E. N., & Ernst, T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.039 · Cited by 205
Achim, C. L., Heyes, M. P., & Wiley, C. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116518 · Cited by 204
Vasan, A., Renjifo, B., Hertzmark, E., Chaplin, B., Msamanga, G., Essex, M., Fawzi, W., & Hunter, D. (2006) · Clinical Infectious Diseases · doi:10.1086/499952 · Cited by 201
CSF amyloid β42 and tau levels correlate with AIDS dementia complex
Brew, B. J., Pemberton, L., Blennow, K., Wallin, A., & Hagberg, L. (2005) · Neurology · doi:10.1212/01.wnl.0000183293.95787.b7 · Cited by 199
Everall, I., Vaida, F., Khanlou, N., Lazzaretto, D., Achim, C., Letendre, S., Moore, D., Ellis, R., Cherner, M., Gelman, B., et al. (2009) · Journal of Neurovirology · doi:10.3109/13550280903131915 · Cited by 181
The Neuropathology of HIV/AIDS
Anthony, I. C., & Bell, P. J. E. (2008) · International Review of Psychiatry · doi:10.1080/09540260701862037 · Cited by 174
Edén, A., Price, R. W., Spudich, S., Fuchs, D., Hagberg, L., & Gisslén, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523648 · Cited by 174
Gurwell, J. A., Nath, A., Sun, Q., Zhang, J., Martin, K. M., Chen, Y., & Hauser, K. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00461-9 · Cited by 167
Calmy, A., Gayet-Ageron, A., Montecucco, F., Nguyen, A., Mach, F., Burger, F., Ubolyam, S., Carr, A., Ruxungtham, K., Hirschel, B., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832995fa · Cited by 159
Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis
Cherner, M., Masliah, E., Ellis, R. J., Marcotte, T. D., Moore, D. J., Grant, I., Heaton, R. K., & HIV Neurobehavioral Research Center Group (2002) · Neurology · doi:10.1212/01.wnl.0000034175.11956.79 · Cited by 159
Anderson, E., Zink, W. E., Xiong, H., & Gendelman, H. E. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200210012-00004 · Cited by 159
Anthony, I. C., Ramage, S. N., Carnie, F. W., Simmonds, P., & Bell, J. E. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0037-0 · Cited by 158
Wallet, M. A., Rodriguez, C. A., Yin, L., Saporta, S., Chinratanapisit, S., Hou, W., Sleasman, J. W., & Goodenow, M. M. (2010) · AIDS · doi:10.1097/qad.0b013e328339e228 · Cited by 153
Patel, K., Ming, X., Williams, P. L., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832dc041 · Cited by 153
Ances, B. M., Vaida, F., Yeh, M. J., Liang, C. L., Buxton, R. B., Letendre, S. L., McCutchan, J. A., & Ellis, R. J. (2010) · The Journal of Infectious Diseases · doi:10.1086/649899 · Cited by 151
Schweinsburg, B. C., Taylor, M. J., Alhassoon, O. M., González, R., Brown, G. G., Ellis, R. J., Letendre, S. L., Videen, J. S., McCutchan, J. A., Patterson, T. L., et al. (2005) · Journal of NeuroVirology · doi:10.1080/13550280591002342 · Cited by 147
HIV Infection of the Central Nervous System: Clinical Features and Neuropathogenesis
Lomax, L. B., Gill, M. J., & Power, C. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.04.002 · Cited by 147
McArthur, J. C., McDermott, M., McClernon, D. R., Hillaire, C. S., Conant, K., Marder, K. S., Schifitto, G., Selnes, O. A., Sacktor, N. C., Stern, Y., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.11.1687 · Cited by 142
Cardenas, V. A., Meyerhoff, D. J., Studholme, C., Kornak, J., ROTHLIND, J. C., Lampiris, H. W., Neuhaus, J., Grant, R. T., Chao, L. L., Truran, D., et al. (2009) · Journal of NeuroVirology · doi:10.1080/13550280902973960 · Cited by 141
Effects of HIV-1 infection and aging on neurobehavioral functioning
Cherner, M., Ellis, R. J., Lazzaretto, D., Young, C., Mindt, M. R., Atkinson, J. H., Grant, I., & Heaton, R. K. (2004) · AIDS · doi:10.1097/00002030-200401001-00005 · Cited by 140
Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., Qi, M., Toh, J., Xu, G., Prasad, P. N., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.093 · Cited by 138
Sacktor, N. C., Nakasujja, N., Skolasky, R. L., Rezapour, M., Robertson, K., Musisi, S., Katabira, E. T., Ronald, A., Clifford, D. B., Laeyendecker, O. B., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605284 · Cited by 137
Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa
Sacktor, N. C., Nakasujja, N., Skolasky, R. L., Robertson, K., Wong, M., Musisi, S., Ronald, A., & Katabira, E. T. (2006) · Neurology · doi:10.1212/01.wnl.0000225183.74521.72 · Cited by 136
Mechanisms of Neuroimmunity and Neurodegeneration Associated with HIV-1 Infection and AIDS
Kaul, M., & Lipton, S. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9011-9 · Cited by 136
Ferris, M. J., Mactutus, C. F., & Booze, R. M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.01.004 · Cited by 135
An update on the neuropathology of HIV in the HAART era
Bell, J. E. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.02004.x · Cited by 131
The diagnostic utility of elevation in cerebrospinal fluid β 2 ‐microglobulin in HIV‐1 dementia
McArthur, J. C., Nance‐Sproson, T. E., Griffin, D. E., Hoover, D. R., Selnes, O. A., Miller, E. N., Margolick, J. B., Cohen, B. A., Farzadegan, H., & Saah, A. J. (1992) · Neurology · doi:10.1212/wnl.42.9.1707 · Cited by 131
Does highly active antiretroviral therapy improve neurocognitive function? A systematic review
Joska, J. A., Gouse, H., Paul, R. H., Stein, D. J., & Flisher, A. J. (2010) · Journal of NeuroVirology · doi:10.3109/13550281003682513 · Cited by 129
Fischer, T., Croul, S. E., Adeniyi, A., Rybicka, K., Morgello, S., Khalili, K., & Rappaport, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63767-4 · Cited by 129
HIV Dementia and the Basal Ganglia
Berger, J. R., & Nath, A. (1997) · Intervirology · doi:10.1159/000150539 · Cited by 128
Brown, B. K., Darden, J. M., Tovanabutra, S., Oblander, T., Frost, J. D., Sanders‐Buell, E., de Souza, M. S., Birx, D. L., McCutchan, F. E., & Polonis, V. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6089-6101.2005 · Cited by 128
Xu, J., & Ikezu, T. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9136-0 · Cited by 127
Heyes, M. P. (2001) · Brain · doi:10.1093/brain/124.5.1033 · Cited by 126
Cocaine opens the blood-brain barrier to HIV-1 invasion
Zhang, L., Looney, D. J., Taub, D. D., Chang, S. L., Way, D., Witte, M. H., Graves, M. C., & Fiala, M. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114228 · Cited by 125
Greater Than Age-Related Changes in Brain Diffusion of HIV Patients After 1 Year
Chang, L., Wong, V. S. S., Nakama, H., Watters, M. R., Ramones, D., Miller, E. N., Cloak, C. C., & Ernst, T. M. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9120-8 · Cited by 123
The shifting patterns of HIV encephalitis neuropathology
Everall, I., Hansen, L. A., & Masliah, E. (2005) · Neurotoxicity Research · doi:10.1007/bf03033819 · Cited by 122
Evolution of HIV dementia with HIV infection
Nath, A., Schiess, N., Venkatesan, A., Rumbaugh, J. A., Sacktor, N. C., & McArthur, J. C. (2008) · International Review of Psychiatry · doi:10.1080/09540260701861930 · Cited by 120
A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection
Kraft-Terry, S. D., Buch, S. J., Fox, H. S., & Gendelman, H. E. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.042 · Cited by 119
Guo, C., Li, Y., Tian, S., Wang, X., Douglas, S. D., & Ho, W. (2002) · Journal of Investigative Medicine · doi:10.1136/jim-50-06-03 · Cited by 119
Neurocognitive impairment among HIV‐positive individuals in Botswana: a pilot study
Lawler, K. A., Mosepele, M., Ratcliffe, S. J., Seloilwe, E., Steele, K. T., Nthobatsang, R., & Steenhoff, A. P. (2010) · Journal of the International AIDS Society · doi:10.1186/1758-2652-13-15 · Cited by 118
Winston, A., Duncombe, C. J., Li, P. C., Gill, M. J., Kerr, S. J., Puls, R. L., Petoumenos, K., Taylor-Robinson, S. D., Emery, S., & Cooper, D. A. (2010) · Clinical Infectious Diseases · doi:10.1086/650743 · Cited by 118
Brew, B. J., Dunbar, N., Pemberton, L. A., & Kaldor, J. M. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.294 · Cited by 116
Lipoprotein particle subclasses, cardiovascular disease and HIV infection
Duprez, D. A., Kuller, L. H., Tracy, R. P., Otvos, J. D., Cooper, D. A., Hoy, J., Neuhaus, J., Paton, N. I., Friis‐Møller, N., Lampe, F. C., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.001 · Cited by 111
Methadone Enhances Human Immunodeficiency Virus Infectionof Human Immune Cells
Li, Y., Wang, X., Tian, S., Guo, C., Douglas, S. D., & Ho, W. (2002) · The Journal of Infectious Diseases · doi:10.1086/338011 · Cited by 111
Reingold, J. S., WANKE, C. A., Kotler, D. P., Lewis, C. E., Tracy, R. P., Heymsfield, S. B., Tien, P. C., Bacchetti, P., Scherzer, R., Grünfeld, C., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181685727 · Cited by 109
Zhou, H., Pandak, W. M., Lyall, V., Natarajan, R., & Hylemon, P. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012898 · Cited by 106
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches
Kaul, M. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328329cf3c · Cited by 103 · cited 2×
“Enhancement of HIV replication in MDM by stimulants (cocaine and METH) has been consistently demonstrated in vitro, and the expected consequence of enhanced HIV replication in MDM is enhanced neurodegeneration through enhanced production of neurotoxic factors from infected and activated macrophages within the CNS [3,8…”
BackgroundNeurobiology of Multiple Insults: HIV-1-Associated Brain Disorders in Those Who Use Illicit Drugs
Bell, J. E., Arango, J.-C., & Anthony, I. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9018-2 · Cited by 101
Brew, B. J., Bhalla, R. B., Paul, M., Sidtis, J. J., Keilp, J. J., Sadler, A. E., Gallardo, H. F., McArthur, J. C., Schwartz, M. K., & Price, R. W. (1992) · AIDS · doi:10.1097/00002030-199205000-00004 · Cited by 100
Zhou, H., Gurley, E. C., Brimson, S., Ding, H., Fang, Y., Xu, Z., Pandak, W. M., & Hylemon, P. B. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00182.2006 · Cited by 100
Marcondes, M. C. G., Flynn, C. T., Watry, D. D., Zandonatti, M. A., & Fox, H. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090953 · Cited by 98
van Vonderen, M. G. A., Hassink, E. A. M., van Agtmael, M. A., Stehouwer, C. D. A., Danner, S. A., Reiss, P., & Smulders, Y. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/597475 · Cited by 93
Methamphetamine Enhances HIV-1 Infectivity in Monocyte Derived Dendritic Cells
Nair, M., Saiyed, Z. M., Nair, N. M., Gandhi, N. H., Rodríguez, J. W., Boukli, N. M., Provencio‐Vasquez, E., Malow, R. M., & Míguez‐Burbano, M. J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9128-0 · Cited by 91
HIV‐1 neuropathogenesis: glial mechanisms revealed through substance abuse
Hauser, K. F., El‐Hage, N., Stiene‐Martin, A., Maragos, W. F., Nath, A., Persidsky, Y., Volsky, D. J., & Knapp, P. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04227.x · Cited by 88
Effect of aging on brain metabolism in antiretroviral-naive HIV patients
Ernst, T., & Chang, L. (2004) · AIDS · doi:10.1097/00002030-200401001-00009 · Cited by 85
HIV, Antiretroviral Therapies, and the Brain
Liner, K. J., Ro, M. J., & Robertson, K. R. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0042-8 · Cited by 83
Kumar, R., Torres, C. G., Yamamura, Y., Rodríguez, I. V., Martínez, M. I., Staprans, S. I., Donahoe, R. M., Kraiselburd, E., Stephens, E. B., & Kumar, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11425-11428.2004 · Cited by 83
Dhillon, N. K., Williams, R., Peng, F., Tsai, Y.-J., Dhillon, S., Nicolay, B., Gadgil, M., Kumar, A., & Buch, S. J. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701528684 · Cited by 81
Lucas, G. M. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.09.025 · Cited by 81
Human immunodeficiency virus–associated neurocognitive disorder
Nath, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05277.x · Cited by 80
Avison, M. J., Nath, A., Greene, R. A., Schmitt, F. A., Bales, R. A., Ethisham, A., Greenberg, R. N., & Berger, J. R. (2004) · Journal of NeuroVirology · doi:10.1080/13550280490463532 · Cited by 80
The effects of illicit drugs on the HIV infected brain
Anthony, I., Arango, J.-C., Stephens, B. C., Simmonds, P., & Bell, J. E. (2007) · Frontiers in bioscience · doi:10.2741/2762 · Cited by 80
Fiala, M., Eshleman, A. J., Cashman, J. R., Lin, J., Lossinsky, A. S., Suarez, V., Yang, W., Zhang, J., Popik, W., Singer, E. J., et al. (2005) · Journal of NeuroVirology · doi:10.1080/13550280590952835 · Cited by 80
Antiretroviral Treatment Alters Relationship between Mcp-1 and Neurometabolites in HIV Patients
Chang, L., Ernst, T. M., Hillaire, C. S., & Conant, K. E. (2004) · Antiviral Therapy · doi:10.1177/135965350400900302 · Cited by 77
Dave, R. S., & Khalili, K. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22592 · Cited by 76
Neurocognitive consequences of HIV in southern India:A preliminary study of clade C virus
YEPTHOMI, T., PAUL, R., VALLABHANENI, S., KUMARASAMY, N., TATE, D. F., SOLOMON, S., & FLANIGAN, T. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060516 · Cited by 73
Selegiline and oxidative stress in HIV-associated cognitive impairment
Schifitto, G., Yiannoutsos, C. T., Ernst, T., NAVIA, B. A., Nath, A., Sacktor, N. C., Anderson, C., Marra, C. M., & Clifford, D. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c51a48 · Cited by 69
Gras, G. S., Chrétien, F., Decouvelaere, A., Pavec, G. L., Porcheray, F., Bossuet, C., Léone, C., Mialocq, P., Dereuddre‐Bosquet, N., Clayette, P., et al. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00020.x · Cited by 68
DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-β1
Happel, C., Steele, A. D., Finley, M. J., Kutzler, M. A., & Rogers, T. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1007685 · Cited by 65
Reynolds, J. L., Mahajan, S. D., Bindukumar, B., et al. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.034 · Cited by 63
Kolson, D. L., & González‐Scarano, F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10553 · Cited by 58
Self-citationPeterson, P. K., Gekker, G., Hu, S., Cabral, G. A., & Lokensgard, J. R. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.026 · Cited by 57
Nair, M., Mahajan, S. D., Schwartz, S. A., Reynolds, J. L., Whitney, R., Bernstein, Z., Chawda, R. P., Sykes, D., Hewitt, R. G., & Hsiao, C. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6617 · Cited by 56
Schütt, M., Zhou, J., Meier, M., & Klein, H. H. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05620 · Cited by 56
The blood brain barrier in HIV infection
Joseph, R. E. (2004) · Frontiers in bioscience · doi:10.2741/1427 · Cited by 55
Ho, W., Guo, C., Yuan, C., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056697 · Cited by 54
Pharmacogenetics of adverse effects due to antiretroviral drugs.
Vidal, F., Gutiérrez, F., Gutiérrez, M. D. M., Olona, M., Sánchez, V., Mateo, G. M., Peraire, J., Viladés, C., Veloso, S., López-Dupla, M., et al. (2010) · PubMed · Cited by 53
Quinolinic acid production is related to macrophage tropic isolates of HIV-1
Brew, B. J., Corbeil, J., Pemberton, L. A., Evans, L. A., Saito, K., Penny, R., Cooper, D. A., & Heyes, M. P. (1995) · Journal of NeuroVirology · doi:10.3109/13550289509111026 · Cited by 53
Impact of Opiate–HIV-1 Interactions on Neurotoxic Signaling
Hauser, K. F., El‐Hage, N., Buch, S. K., Nath, A., Tyor, W. R., Bruce‐Keller, A. J., & Knapp, P. E. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9000-4 · Cited by 51
Mortality and HIV transmission among male Vietnamese injection drug users
Quan, V. M., Minh, N. L., Hà, T. V., Ngoc, N. P., Vu, P. T., Celentano, D. D., Mo, T. T., & Go, V. F.-L. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03175.x · Cited by 51
Robertson, K., Liner, J., Hakim, J. G., Sankalé, J., Grant, I., Letendre, S. L., Clifford, D. B., Diop, A. G., Jaye, A., Kanmogne, G. D., et al. (2010) · Journal of NeuroVirology · doi:10.3109/13550284.2010.489597 · Cited by 47
Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction
Grovit‐Ferbas, K., & Harris‐White, M. E. (2010) · Immunologic Research · doi:10.1007/s12026-010-8166-x · Cited by 44
κ-Opioid Receptor Ligands Inhibit Cocaine-Induced HIV-1 Expression in Microglial Cells
Gekker, G., Hu, S., Wentland, M. P., Bidlack, J. M., Lokensgard, J. R., & Peterson, P. K. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060160 · Cited by 44
PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
Tisch, S. H., & Brew, B. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b04b0d · Cited by 44
HIV-Associated Dementia: New Insights into Disease Pathogenesis and Therapeutic Interventions
Swindells, S., Zheng, J., & Gendelman, H. E. (1999) · AIDS Patient Care and STDs · doi:10.1089/apc.1999.13.153 · Cited by 43
Vehmas, A., Lieu, J., Pardo, C. A., McArthur, J. C., & Gartner, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.035 · Cited by 35
Direct interference of HIV protease inhibitors with pancreatic �-cell function
D�fer, M., Neye, Y., Krippeit‐Drews, P., & Drews, G. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0933-6 · Cited by 30
Vincendeau, M., Kramer-Hämmerle, S., Hadian, K., Rothenaigner, I., Bell, J. E., Hauck, S. M., Bickel, C., Nagel, D., Kremmer, E., Werner, T., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833e8758 · Cited by 29
Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana
Montano, M. A., Rarick, M., Sebastiani, P., Brinkmann, P., Russell, M. L., Navis, A., Wester, C., Thior, I., & Essex, M. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364297 · Cited by 29
Effect of Morphine on the Neuropathogenesis of SIVmac Infection in Indian Rhesus Macaques
Marcario, J. K., Riazi, M., Adany, I., Kenjale, H., Fleming, K., Marquis, J. G., Nemon, O., Mayo, M. S., Yankee, T. M., Narayan, O., et al. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9085-z · Cited by 24
The incidence of and risk factors for HIV-associated cognitive–motor complex among patients on HAART
Jevtović, D., Vanovac, V., Veselinović, M., Salemović, D., Ranin, J. T., & Stefanova, E. D. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.09.015 · Cited by 21
Chittiprol, S., Kumar, A. M., Satishchandra, P., Shetty, K. T., Rao, R. S. B., Subbakrishna, D. K., Philip, M., Satish, K. S., Kumar, H., & Kumar, M. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.006 · Cited by 21
Effects of HIV-1 infection and aging on neurobehavioral functioning
Cherner, M., Ellis, R. J., Lazzaretto, D., Young, C., Mindt, M. R., Atkinson, J. H., Grant, I., & Heaton, R. K. (2004) · AIDS · doi:10.1097/00002030-200418001-00005 · Cited by 20
Immunology as it Pertains to Drugs of Abuse, AIDS and the Neuroimmune Axis: Mediators and Traffic
Rogers, T. J. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9247-2 · Cited by 9
Cited by
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 496
Toxoplasma Effectors Targeting Host Signaling and Transcription
Hakimi, M.-A., Olias, P., & Sibley, L. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-17 · Cited by 339
Role of Exosomes/Microvesicles in the Nervous System and Use in Emerging Therapies
Lai, C. P.-K., & Breakefield, X. O. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00228 · Cited by 315
Endoplasmic reticulum stress and inflammation in the central nervous system
Sprenkle, N. T., Sims, S. G., Sánchez, C. L., & Meares, G. P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0183-y · Cited by 294
Metadata
- Authors
- Gannon, P., Khan, M. Z., & Kolson, D. L.
- Venue
- Current Opinion in Neurology
- Published
- 2011-06
- Volume
- 24
- Issue
- 3
- Pages
- 275-283
- ISSN
- 1350-7540 (ISSN-L)
- OpenAlex
- W1978155055
- Cited by
- 271
- References
- 142
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.